Picture of Eurofins Scientific SE logo

ERF — Eurofins Scientific SE News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Eurofins drops as organic growth disappoints

BUZZ-Eurofins drops as organic growth disappoints

- ** Shares in Eurofins Scientific EUFI.PA fall 6% after the laboratory testing group reported weaker-than-expected first-half organic growth

** Jeffries says the company's H1 organic growth of 2.7% is "well below expectations" and "disappoints again," with second-quarter organic growth of about 3% missing consensus of 4.2%, impacted by weak biopharma growth

** The broker adds that Eurofins' full-year outlook is unchanged, but organic growth targets now look more conditional, requiring acceleration in the second-half

** TP ICAP Midcap says biopharma remains the key factor in Eurofins' ability to return to its medium-term organic growth ambition

** Shares are on track for the worst day since April 22, when they closed 9.7% lower after "disappointing Q1"


(Reporting by Aleksandra Kret in Gdansk)

((Aleksandra.Kret@thomsonreuters.com))

Recent news on Eurofins Scientific SE

See all news